Singapore markets open in 1 hour 13 minutes

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.0600-0.0800 (-3.74%)
At close: 03:55PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
31/03/2019
31/03/2018
Total revenue
77,063
79,660
52,432
25,363
7,751
Cost of revenue
39,281
37,655
22,990
10,380
3,847
Gross profit
37,782
42,005
29,442
14,983
3,904
Operating expenses
Research development
7,175
4,596
1,098
-
-
Selling general and administrative
43,092
36,172
28,934
15,615
6,088
Total operating expenses
50,746
41,274
30,482
15,664
6,099
Operating income or loss
-12,964
731
-1,041
-680.6943
-2,195
Interest expense
11,006
9,819
6,442
2,904
918.8987
Total other income/expenses net
-1,509
-22,416
3,254
-1,295
386.6588
Income before tax
-25,476
-31,501
-5,188
-4,719
-2,697
Income tax expense
-5,761
-3,237
-790.4386
166.2867
-
Income from continuing operations
-19,715
-28,264
-4,397
-4,885
-2,697
Net income
-19,715
-28,264
-4,397
-4,885
-2,697
Net income available to common shareholders
-19,715
-28,264
-4,397
-4,885
-2,697
Basic EPS
-
-1.86
-0.30
-0.49
-0.48
Diluted EPS
-
-1.86
-0.30
-0.49
-0.48
Basic average shares
-
15,197
14,360
9,909
5,683
Diluted average shares
-
15,197
14,360
9,909
5,683
EBITDA
-
-15,704
4,961
119.3342
-1,599